| 1 |
Fas ligand
(2428 times)
|
Allergy and Immunology
(622 times)
|
TNF (117 times)
TNF-alpha (96 times)
sFasL (76 times)
|
1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
|
| 2 |
Fas-Fas ligand
(81 times)
|
Allergy and Immunology
(26 times)
|
sFas (8 times)
sFasL (7 times)
GVHD (3 times)
|
1996 T cells commit suicide, but B cells are murdered!
|
| 3 |
Fas and its ligand
(28 times)
|
Allergy and Immunology
(7 times)
|
AI (1 time)
AICD (1 time)
bFGF (1 time)
|
1997 HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
|
| 4 |
anti-Fas ligand
(20 times)
|
Allergy and Immunology
(10 times)
|
SLE (3 times)
cyt c (2 times)
mAb (2 times)
|
1999 Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
|
| 5 |
Fas receptor by its ligand
(8 times)
|
Allergy and Immunology
(2 times)
|
AIH (1 time)
BS-IV (1 time)
CFA (1 time)
|
1997 Fas ligand expression and function in systemic lupus erythematosus.
|
| 6 |
Fas (Apo-1/CD95) ligand
(6 times)
|
Pathology
(2 times)
|
AICD (1 time)
mAb (1 time)
MoAbs (1 time)
|
1997 Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.
|
| 7 |
receptor-Fas ligand
(5 times)
|
Biochemistry
(1 time)
|
ECTV (2 times)
ACE2 (1 time)
CNS (1 time)
|
2003 Caspase-8 expression and proteolysis in human brain after severe head injury.
|
| 8 |
factor associated suicide ligand
(4 times)
|
Cell Biology
(1 time)
|
Fas (2 times)
HE (2 times)
H-dose (1 time)
|
2013 Licochalcone A induces apoptosis in KB human oral cancer cells via a caspase-dependent FasL signaling pathway.
|
| 9 |
Fas (CD95/APO-1) ligand
(4 times)
|
Cardiology
(1 time)
|
BRK (1 time)
CHX (1 time)
gld (1 time)
|
2000 Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis.
|
| 10 |
Fas (Apo-1/CD95) and its ligand
(3 times)
|
Allergy and Immunology
(3 times)
|
PKCepsilon (1 time)
PPAR (1 time)
|
1997 Fas ligand expression is restricted to nonlymphoid thymic components in situ.
|
| 11 |
Fas with its ligand
(3 times)
|
Pathology
(1 time)
|
B2M (1 time)
CRP (1 time)
HO-1 (1 time)
|
1999 [Increased serum soluble Fas ligand in hyperthyroid Graves' disease].
|
| 12 |
anti-Fas antibody or Fas ligand
(2 times)
|
Biochemistry
(1 time)
|
CHX (1 time)
ECH (1 time)
FADD (1 time)
|
2003 Epoxycyclohexenone inhibits Fas-mediated apoptosis by blocking activation of pro-caspase-8 in the death-inducing signaling complex.
|
| 13 |
Fas (CD-95/APO-1) and its ligand
(2 times)
|
Neoplasms
(2 times)
|
---
|
1999 Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance.
|
| 14 |
Fas ligation with its cognate ligand
(2 times)
|
Drug Therapy
(1 time)
|
IL (2 times)
sFas (2 times)
WT (2 times)
|
2007 Protection against lipopolysaccharide-induced myocardial dysfunction in mice by cardiac-specific expression of soluble Fas.
|
| 15 |
Fas receptor and its cognate ligand
(2 times)
|
Hematology
(2 times)
|
---
|
1998 Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles.
|
| 16 |
Fas/Apo-1 and its ligand
(2 times)
|
Medicine
(1 time)
|
LPC (1 time)
NF-kappaB (1 time)
|
1997 Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
|
| 17 |
FasR to its natural ligand
(2 times)
|
Neoplasms
(2 times)
|
CNS (2 times)
NGF/TNF (2 times)
PCD (2 times)
|
1999 Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
|
| 18 |
fibroblast-associated cell-surface ligand
(2 times)
|
Neurology
(1 time)
|
ALS (1 time)
IL (1 time)
TNF (1 time)
|
2006 Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
|
| 19 |
anti-Fas Abs or soluble Fas
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1998 Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
|
| 20 |
anti-Fas ligand antibody
(1 time)
|
Pediatrics
(1 time)
|
ADR (1 time)
|
2002 Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative.
|
| 21 |
apoptosis--Fas, Fas ligand
(1 time)
|
Ophthalmology
(1 time)
|
---
|
2000 The role of apoptosis in the early corneal wound healing after excimer laser keratectomy in the rat.
|
| 22 |
CTLA4-Fas ligand
(1 time)
|
Genetics, Medical
(1 time)
|
AdCTLA4-FasL (1 time)
|
2004 Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
|
| 23 |
factor receptor superfamily, and its ligand
(1 time)
|
Biochemistry
(1 time)
|
---
|
1999 Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
|
| 24 |
factor-related apoptosis ligand
(1 time)
|
|
cfDNA (1 time)
GLU1 (1 time)
NSCLC (1 time)
|
2022 Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non-Small Cell Lung Cancer from Tuberculosis.
|
| 25 |
factors--Fas, Fas ligand
(1 time)
|
Dentistry
(1 time)
|
ssDNA (1 time)
|
2001 Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
|
| 26 |
family, and its ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
TNFR (1 time)
|
1997 Identification of amino acid residues important for ligand binding to Fas.
|
| 27 |
Fas (Apo-1/CD95) and its specific ligand
(1 time)
|
Neoplasms
(1 time)
|
---
|
2010 Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
|
| 28 |
Fas (Apo-1/CD95) receptor/ligand
(1 time)
|
Hematology
(1 time)
|
mAb (1 time)
|
1999 On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
|
| 29 |
Fas activation by ligand
(1 time)
|
Neurology
(1 time)
|
FADD (1 time)
FLIP (1 time)
RIP (1 time)
|
1999 Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB.
|
| 30 |
Fas and its physiological ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2012 Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
|
| 31 |
Fas and its receptor ligand
(1 time)
|
Pathology
(1 time)
|
IHC (1 time)
|
2007 Participation of the Fas and Fas ligand systems in apoptosis during atrophy of the rat submandibular glands.
|
| 32 |
Fas and soluble Fas ligand
(1 time)
|
Toxicology
(1 time)
|
EM (1 time)
|
2008 Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria.
|
| 33 |
Fas antigen ligand
(1 time)
|
Epidemiology
(1 time)
|
AREG (1 time)
CRC (1 time)
Flt3L (1 time)
|
2017 Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.
|
| 34 |
Fas death ligand
(1 time)
|
Endocrinology
(1 time)
|
Dkkl1 (1 time)
|
2008 Dickkopf-like1 regulates postpubertal spermatocyte apoptosis and testosterone production.
|
| 35 |
Fas interaction with its ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1997 Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
|
| 36 |
Fas ligand molecules
(1 time)
|
Allergy and Immunology
(1 time)
|
AICD (1 time)
|
1997 Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
|
| 37 |
Fas ligand receptors
(1 time)
|
Biochemistry
(1 time)
|
---
|
2009 Helicobacter pylori increases expression of proapoptotic markers Fas and FasL on CD4 lymphocytes in children.
|
| 38 |
Fas ligand-Fc
(1 time)
|
Neoplasms
(1 time)
|
HNSCC (1 time)
|
2018 Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.
|
| 39 |
Fas natural ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2000 Immature B cells in bone marrow express Fas/FasL.
|
| 40 |
Fas receptor ligand
(1 time)
|
Biochemistry
(1 time)
|
ECM (1 time)
PVLA (1 time)
|
2002 Cell adhesion aside from integrin system can abrogate anoikis in rat liver cells by down-regulation of FasL expression, not by activation of PI-3K/Akt and ERK signaling pathway.
|
| 41 |
Fas receptor with its own ligand
(1 time)
|
Endocrinology
(1 time)
|
HT (1 time)
|
1998 Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
|
| 42 |
Fas with its cognate ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
AICD (1 time)
|
2006 Age related changes in Fas (CD95) and Fas ligand gene expression and cytokine profiles in healthy Indians.
|
| 43 |
Fas with its membrane-bound ligand
(1 time)
|
Biochemistry
(1 time)
|
SH3 (1 time)
|
1995 Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain.
|
| 44 |
Fas-to-Fas-ligand
(1 time)
|
Endocrinology
(1 time)
|
---
|
2001 Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.
|
| 45 |
Fas/APO-1/CD95 ligand
(1 time)
|
Reproductive Medicine
(1 time)
|
Fas (1 time)
RT-PCR (1 time)
|
2006 Expression and localization of Fas ligand and Fas during atresia in porcine ovarian follicles.
|
| 46 |
fatty acid synthetase ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
Apaf-1 (1 time)
Bcl-2 (1 time)
caspase-2 (1 time)
|
2017 Sodium butyrate enhanced physical barrier function referring to Nrf2, JNK and MLCK signaling pathways in the intestine of young grass carp (Ctenopharyngodon idella).
|
| 47 |
FS-7-associated surface antigen ligand
(1 time)
|
Brain
(1 time)
|
Cat (1 time)
CSPGs (1 time)
CXCL (1 time)
|
2022 Potential neurotoxic activity of diverse molecules released by astrocytes.
|
| 48 |
function and concurrent expression of its ligand
(1 time)
|
Gynecology
(1 time)
|
RT-PCR (1 time)
|
2003 Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
|
| 49 |
functional significance of the Fas/Fas-ligand
(1 time)
|
Cell Biology
(1 time)
|
---
|
2008 The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.
|
| 50 |
functional status of Fas ligand
(1 time)
|
Neoplasms
(1 time)
|
---
|
2000 Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
|
| 51 |
functional, cell-surface Fas ligand
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2001 Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia.
|
A Search Service for Abbreviation / Long Form